November 16, 2020
Stephen I. Katz, M.D., Ph.D.

Stephen I. Katz, M.D., Ph.D.

Dear Colleagues,

We at NIAMS are excited as we look forward to the arrival of Lindsey Criswell as the new Director but our thoughts also turn back to memories of our previous Director, Steve Katz. He was a unique voice who guided the NIAMS as director for more than two decades and who spent his career mentoring the next generations of researchers. With this in mind, I am pleased share news of new awards that give the NIH a unique way to encourage the scientists of tomorrow.

The Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) and the Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Humans Required) are now accepting applications.

Class Photo
Dr. Steve Katz, front row center, with NIAMS summer interns and staff in 2017.

While Steve was internationally known for his contributions to the field of dermatology, he also saw great value in looking beyond the borders of any single area of research. The new awards are infused with this spirit of intellectual exploration. The purpose of these R01 Research Project Grants is to support early-stage investigators (ESIs) who wish to propose research projects in a new direction for which preliminary data do not exist. The change in research direction could involve, for example, a new approach, methodology, technique, discipline, therapeutic target, and/or new paradigm.

NIH Director Francis S. Collins, M.D., Ph.D., a close colleague of Steve’s, said, “I can’t think of a better way to commemorate Steve’s tireless dedication to empowering the scientists of tomorrow than through these awards. We hope the recipients of these awards will help generate bold new ideas to help move medical research forward in unexpected ways.”

If Steve were with us today, he would be first in line for a chance to read the incoming applications. I know he would be proud to see his legacy live on through these awards that foster innovative new directions from our next generation of scientists.

I encourage you to apply, and to share the announcements with interested colleagues.

Robert H. Carter, M.D.
Acting Director
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health